Phase I clinical trial of the first drug to successfully inhibit the MYC gene that drives many common cancers
Researchers report that a drug targeting the cancer-causing gene MYC inhibits the function of the gene in a phase I clinical trial. Until now, no other drug has been able to do this safely and effectively.
Oct 26, 2022
0
10
